Clavel-Chapelon F - Search Results

1

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F. Fournier A, et al. J Clin Oncol. 2008 Mar 10;26(8):1260-8. doi: 10.1200/JCO.2007.13.4338. J Clin Oncol. 2008. PMID: 18323549 Free PMC article.

2

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.

Fournier A, Berrino F, Clavel-Chapelon F. Fournier A, et al. Breast Cancer Res Treat. 2008 Jan;107(1):103-11. doi: 10.1007/s10549-007-9523-x. Epub 2007 Feb 27. Breast Cancer Res Treat. 2008. PMID: 17333341 Free PMC article.

3

Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.

Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. Touillaud MS, et al. J Natl Cancer Inst. 2007 Mar 21;99(6):475-86. doi: 10.1093/jnci/djk096. J Natl Cancer Inst. 2007. PMID: 17374837 Free PMC article.

4

Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women.

Lajous M, Boutron-Ruault MC, Fabre A, Clavel-Chapelon F, Romieu I. Lajous M, et al. Am J Clin Nutr. 2008 May;87(5):1384-91. doi: 10.1093/ajcn/87.5.1384. Am J Clin Nutr. 2008. PMID: 18469262 Free article.

5

Progestagens use before menopause and breast cancer risk according to histology and hormone receptors.

Fabre A, Fournier A, Mesrine S, Gompel A, Desreux J, Berrino F, Boutron-Ruault MC, Romieu I, Clavel-Chapelon F. Fabre A, et al. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2723-8. doi: 10.1158/1055-9965.EPI-08-0056. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18843015

6

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Fournier A, et al. J Clin Oncol. 2009 Nov 1;27(31):5138-43. doi: 10.1200/JCO.2008.21.6432. Epub 2009 Sep 14. J Clin Oncol. 2009. PMID: 19752341 Free PMC article.

7

Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study.

Cottet V, Touvier M, Fournier A, Touillaud MS, Lafay L, Clavel-Chapelon F, Boutron-Ruault MC. Cottet V, et al. Am J Epidemiol. 2009 Nov 15;170(10):1257-67. doi: 10.1093/aje/kwp257. Epub 2009 Oct 14. Am J Epidemiol. 2009. PMID: 19828509

8

Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort.

Fagherazzi G, Fabre A, Boutron-Ruault MC, Clavel-Chapelon F. Fagherazzi G, et al. Eur J Cancer Prev. 2010 Mar;19(2):120-5. doi: 10.1097/CEJ.0b013e3283354918. Eur J Cancer Prev. 2010. PMID: 20042864

9

Postmenopausal hormone therapy and asthma onset in the E3N cohort.

Romieu I, Fabre A, Fournier A, Kauffmann F, Varraso R, Mesrine S, Leynaert B, Clavel-Chapelon F. Romieu I, et al. Thorax. 2010 Apr;65(4):292-7. doi: 10.1136/thx.2009.116079. Epub 2010 Feb 8. Thorax. 2010. PMID: 20142267 Free PMC article.

10

Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort.

Engel P, Fagherazzi G, Boutten A, Dupré T, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Engel P, et al. Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2341-50. doi: 10.1158/1055-9965.EPI-10-0264. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20826834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

581 results

Search Page

Filters